" The Company is looking to fund the business by a combination of nanoparticle
sales (including technology access fees to our key customer) as well as a small
capital raise. The Company is planning for these two initiatives to raise on or around
$1.8 million in the short-term with some follow on nanoparticle sales revenues. In
addition to this the Company received $0.2 million in January from nanoparticle
revenues with a further $0.3 million due in early February. The Company will also
be due its 2023 R&D tax incentive (expected on or around Q2 2024), this is
expected to be less than prior years as will only include Australian based costs.
"
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
" The Company is looking to fund the business by a combination...
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
IBX (ASX) Chart |
Day chart unavailable